These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 11726950)
21. Katy, bar the door! HIV entry inhibitors. Martinez LJ Res Initiat Treat Action; 2000 Jun; 6(2):6-12. PubMed ID: 11707878 [No Abstract] [Full Text] [Related]
22. US FDA approves new class of HIV therapeutics. Robertson D Nat Biotechnol; 2003 May; 21(5):470-1. PubMed ID: 12721558 [No Abstract] [Full Text] [Related]
23. Enfuvirtide (Fuzeon) for HIV Infection. Med Lett Drugs Ther; 2003 Jun; 45(1159):49-50. PubMed ID: 12817195 [No Abstract] [Full Text] [Related]
32. New package inserts for efavirenz and T-20. AIDS Clin Care; 2007 Mar; 19(3):24. PubMed ID: 17595717 [No Abstract] [Full Text] [Related]
33. [FDA approved the first of a new class of antiretrovirals for adults and children with advanced HIV infection]. Rev Panam Salud Publica; 2003 Jul; 14(1):57-8. PubMed ID: 12952609 [No Abstract] [Full Text] [Related]
34. Long path to approval. A look back at the road to Fuzeon. GMHC Treat Issues; 2003 Mar; 17(3):1-5. PubMed ID: 12728856 [No Abstract] [Full Text] [Related]
35. 9th National Retrovirus Conference: new treatments, new choices. Laurence J AIDS Patient Care STDS; 2002 May; 16(5):193-5. PubMed ID: 12055025 [No Abstract] [Full Text] [Related]
36. Clinical perspective of fusion inhibitors for treatment of HIV. Rockstroh JK; Mauss S J Antimicrob Chemother; 2004 May; 53(5):700-2. PubMed ID: 15044424 [TBL] [Abstract][Full Text] [Related]
37. HIV fusion and its inhibition in antiretroviral therapy. Greenberg M; Cammack N; Salgo M; Smiley L Rev Med Virol; 2004; 14(5):321-37. PubMed ID: 15334539 [TBL] [Abstract][Full Text] [Related]